Okin, P. M., Devereux, R. B., Harris, K. E., Jern, S., Kjeldsen, S. E., Lindholm, L. H., & Dahlöf, B. (2007). In-treatment resolution or absence of electrocardiographic left ventricular hypertrophy is associated with decreased incidence of new-onset diabetes mellitus in hypertensive patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study. Hypertension (Dallas, Tex. 1979), 50(5), 984. https://doi.org/10.1161/HYPERTENSIONAHA.107.096818
Citace podle Chicago (17th ed.)Okin, Peter M., Richard B. Devereux, Katherine E. Harris, Sverker Jern, Sverre E. Kjeldsen, Lars H. Lindholm, a Björn Dahlöf. "In-treatment Resolution or Absence of Electrocardiographic Left Ventricular Hypertrophy Is Associated with Decreased Incidence of New-onset Diabetes Mellitus in Hypertensive Patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study." Hypertension (Dallas, Tex. 1979) 50, no. 5 (2007): 984. https://doi.org/10.1161/HYPERTENSIONAHA.107.096818.
Citace podle MLA (9th ed.)Okin, Peter M., et al. "In-treatment Resolution or Absence of Electrocardiographic Left Ventricular Hypertrophy Is Associated with Decreased Incidence of New-onset Diabetes Mellitus in Hypertensive Patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study." Hypertension (Dallas, Tex. 1979), vol. 50, no. 5, 2007, p. 984, https://doi.org/10.1161/HYPERTENSIONAHA.107.096818.